Unveiling 4 Analyst Insights On PROCEPT BioRobotics
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
公布关于 PROCEPT 生物机器人的 4 项分析见解
4 analysts have shared their evaluations of PROCEPT BioRobotics (NASDAQ:PRCT) during the recent three months, expressing a mix of bullish and bearish perspectives.
4位分析师分享了他们在最近三个月中对PROCEPT BioRobotics（纳斯达克股票代码：PRCT）的评估，表达了看涨和看跌的观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $70.0, with a high estimate of $75.00 and a low estimate of $58.00. Witnessing a positive shift, the current average has risen by 12.0% from the previous average price target of $62.50.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为70.0美元，最高估计为75.00美元，低估值为58.00美元。当前的平均价格从之前的平均目标价62.50美元上涨了12.0％，这是一个积极的转变。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
In...
在...
登录免费看全文
登录/注册